Researchers at Mount Sinai School of Medicine have found that exposure to three common chemical classes phenols, phthalates and phytoestrogens in young girls may disrupt the timing of pubertal development, and put girls at risk for health complications later in life…
No Comments »
Filed under: Women's Health
Previous research has shown that women with breast cancer are more likely than other women to develop ovarian cancer, but now researchers from the Sahlgrenska Academy at the University of Gothenburg, Sweden, have shown that actually only women with a known Western Swedish mutation behind hereditary breast cancer run this increased risk of ovarian cancer…
No Comments »
Filed under: Women's Health
Poor compliance with breastfeeding recommendations costs the nation at least $13 billion each year, with nearly all of the cost related to infant morbidity and mortality, according to a comprehensive economic analysis.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The Federal Aviation Administration says it will now allow some pilots taking medication for mild to moderate depression to fly airplanes, modifying a policy that until now has kept them out of the cockpit.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA approved the first biodegradable surgical sealant sponge, TachoSil, for use in cardiovascular surgery to stop mild to moderate bleeding in small blood vessels.
No Comments »
Filed under: Pharmacy News
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company’s novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.
No Comments »
Filed under: Pharmacy News
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase II protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin® for the treatment of Parkinson’s disease (PD).
No Comments »
Filed under: Pharmacy News
Altheos, Inc., a privately held early-stage biopharmaceutical company, announced today that it has completed a $20 million Series A financing led by Bay City Capital. New investors Novo A/S, Canaan Partners, Life Science Angels and Atheneos Capital also joined the round. The financing will be used primarily for the development of ATS907, a [...]
No Comments »
Filed under: Pharmacy News
Juventas Therapeutics, a privately held, clinical-stage regenerative medicine company announced it has started enrolling patients in a Phase I clinical trial for JVS-100 to evaluate safety and efficacy in the treatment of patients with Class III heart failure. JVS-100 encodes Stromal Cell-derived Factor-1 (SDF-1) and has been shown in pre-clinical studies to significantly increase cardiac [...]
No Comments »
Filed under: Pharmacy News
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology, today reported financial results for the fourth quarter and fiscal year ended December 31, 2009.
No Comments »
Filed under: Pharmacy News
